Learn About Myxoid Liposarcoma
- Myxoid liposarcoma
- MRCLS
- Myxoid/round cell liposarcoma
- Myxoliposarcoma
Memorial Solid Tumor Group
William Tap is a Hematologist Oncology specialist and a Hematologist in New York, New York. Dr. Tap is rated as an Elite provider by MediFind in the treatment of Myxoid Liposarcoma. His top areas of expertise are Adult Soft Tissue Sarcoma, Gastrointestinal Stromal Tumor, Angiosarcoma, Tissue Biopsy, and Liver Embolization.
Memorial Solid Tumor Group
Sandra Dangelo is an Oncologist in New York, New York. Dr. Dangelo is rated as an Elite provider by MediFind in the treatment of Myxoid Liposarcoma. Her top areas of expertise are Adult Soft Tissue Sarcoma, Synovial Sarcoma, Merkel Cell Carcinoma, Liposarcoma, and Liver Embolization.
Memorial Solid Tumor Group
Mark Dickson is a Hematologist Oncology specialist and a Hematologist in New York, New York. Dr. Dickson is rated as a Distinguished provider by MediFind in the treatment of Myxoid Liposarcoma. His top areas of expertise are Adult Soft Tissue Sarcoma, Liposarcoma, Undifferentiated Pleomorphic Sarcoma, Gastrointestinal Stromal Tumor, and Endoscopy.
Summary: The purpose of this study is to find out whether mirdametinib in combination with palbociclib is an effective and safe treatment for people with metastatic, recurrent, and unresectable liposarcoma. This study will test different doses of mirdametinib in combination with a fixed dose of palbociclib to find the best safe dose for further testing.
Summary: This study is testing two different doses of BTX-A51 to determine if it is safe and tolerable in participants with liposarcoma with MDM2 amplification, myxoid liposarcoma, and CIC-rearranged sarcoma. The name of the study drug used in this research study is: -BTX-A51 (a type of kinase inhibitor)
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center